News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

QuantRx Biomedical Corporation Selects Synova Healthcare Inc. As The Exclusive Distributor Of Its PAD Technology -- To Be Used For The Treatment Of Hemorrhoids



7/17/2006 12:13:14 PM

QuantRx® Biomedical Corporation (OTCBB: QTXB) announced today that it has entered into an exclusive distribution agreement for its PAD technology with Synova Healthcare, a distributor of diagnostic products. Under this agreement, QuantRx® received an up-front payment of $500,000 and is eligible to receive royalties, based upon sales, estimated to be worth multi-million dollars, over the term of the multi-year agreement in return for granting Synova exclusive rights to distribute the PAD technology for sales of Hemorrhoid Products in North America.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES